文献速递关节外科创伤骨科

美国全膝关节置换术后假体周围骨折的再入院费用与危险因素

Costs and Risk Factors for Hospital Readmission After Periprosthetic Knee Fractures in the United States.
PubMed 文献 · J Arthroplasty · 2017-09-23

基于2013年美国全国再入院数据库,纳入1526例接受切开复位内固定(ORIF)和1458例接受翻修全膝关节置换术(TKA)治疗的假体周围骨折(PPFX)患者,90天再入院率分别为20.5%和21.8%。ORIF费用为25,539美元,翻修TKA费用为37,680美元,相关再入院费用分别为15,269美元和16,806美元。再入院危险因素包括高龄、男性、合并症、出院至专业护理机构或带健康助理回家、以及医疗保险或医疗补助保险。

要点

  • PPFX治疗后90天再入院率:ORIF组20.5%,翻修TKA组21.8%。
  • ORIF治疗费用25,539美元,翻修TKA费用37,680美元。
  • 再入院危险因素包括高龄、男性、合并症、出院至专业护理机构或带健康助理回家、医疗保险或医疗补助保险,以及教学医院治疗。

核心结论

  • PPFX导致的费用高于初次和翻修TKA。
  • 本研究突出了PPFX治疗后再入院的危险因素。

研究设计与样本

  • 使用2013年美国全国再入院数据库,选取接受TKA、翻修TKA以及采用ORIF或翻修TKA治疗PPFX的患者。
  • 通过生存分析确定90天再入院率,并使用调整患者和医院特征的Cox比例风险模型识别危险因素。

主要发现

  • 共识别1526例接受ORIF的PPFX患者和1458例接受翻修TKA的患者。
  • 90天再入院率分别为20.5%和21.8%。
  • ORIF组患者更常为女性且合并多种内科疾病。
  • 与再入院相关的患者因素包括高龄、男性、合并症、出院至专业护理机构或带健康助理回家、以及医疗保险或医疗补助保险。
  • 教学医院治疗是唯一发现的医院相关危险因素。

关键数值与推荐

  • ORIF费用为25,539美元,翻修TKA费用为37,680美元。
  • ORIF相关再入院费用为15,269美元,翻修TKA相关再入院费用为16,806美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic fractures (PPFX) around total knee arthroplasty (TKA) are devastating complications with significant morbidity. With growing healthcare costs, hospital readmissions have become a marker for quality healthcare delivery. However, little is known about the risk factors or costs associated with readmission after treatment of PPFX. We sought to identify the patient demographics, prevalence of treatment types (open reduction internal fixation [ORIF] vs revision TKA), 30 and 90-day readmission rates, costs of initial treatment and readmission, and risk factors for readmission. METHODS: We used the 2013 Nationwide Readmissions Database to select patients who underwent TKA, revision TKA, and treatment of PPFX with either ORIF or revision TKA. The 90-day readmission rate was determined through a survival analysis, and risk factors were identified using a cox proportional hazards model that adjusted for patient and hospital characteristics. RESULTS: We identified 1526 patients with PPFX treated with ORIF and 1458 treated with revision TKA. Ninety-day readmissions were 20.5% and 21.8%, respectively. Patients with ORIF were more often female and had multiple medical comorbidities. Patient factors associated with readmission included advanced age, male gender, comorbidities, discharge to a skilled nursing facility or home with health aide, and Medicare or Medicaid insurance. Treatment at a teaching hospital was the only hospital-associated risk factor identified. ORIF cost USD 25,539 and revision THA cost USD 37,680, with associated readmissions costing 15,269 and 16,806, respectively. CONCLUSION: PPFX results in greater costs compared to primary and revision TKA. This study highlights risk factors for readmission after PPFX treatment.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Reeves RA, Schairer WW, Jevsevar DS, et al. Costs and Risk Factors for Hospital Readmission After Periprosthetic Knee Fractures in the United States. J Arthroplasty. 2017. PMID: 29066112. doi:10.1016/j.arth.2017.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。